sanofi-aventis suspends U.S. Eligard sales

QLT (TSX:QLT; QLTI) said U.S. marketing partner sanofi-aventis (Euronext:SAN; SNY) is suspending sales of prostate cancer drug Eligard leuprolide until May 1, when a patent covering method of use that...